Volume 21, Issue 7 (2-2019)
J Arak Uni Med Sci 2019, 21(7): 1-7 |
Back to browse issues page
1- School of Medicine, Arak University of Medical Sciences, Arak, Iran. , masoudrezagholi074@gmail.com
2- Amir Kabir Hospital, Department of Pediatric Nephrology, Arak University of Medical Sciences, Arak, Iran.
2- Amir Kabir Hospital, Department of Pediatric Nephrology, Arak University of Medical Sciences, Arak, Iran.
Abstract: (65277 Views)
Nephrotic syndrome
Nephrotic syndrome is a manifestation of glomerular disease as a proteinuria in the nephrotic and triad of hypoalbuminemia, edema, hyperlipidemia, and high protein in the urine. Nephrotic proteinuria is defined as protein excretion of more than 40 mg/m2 of body surface per hour or protein to creatinine ratio of more than 2-3 at the first morning urine sample. Its annual incidence in most western countries is 2-3 cases per 100000 children per year, and in developing countries it is often higher due to malaria (1). New findings in this area are often about treatment, which are evaluated and reviewed in following.
Nephrotic syndrome is a manifestation of glomerular disease as a proteinuria in the nephrotic and triad of hypoalbuminemia, edema, hyperlipidemia, and high protein in the urine. Nephrotic proteinuria is defined as protein excretion of more than 40 mg/m2 of body surface per hour or protein to creatinine ratio of more than 2-3 at the first morning urine sample. Its annual incidence in most western countries is 2-3 cases per 100000 children per year, and in developing countries it is often higher due to malaria (1). New findings in this area are often about treatment, which are evaluated and reviewed in following.
References
1. Yousefichaijan P, Rezagholizamenjany M, Rafiei F, Taherahmadi H, Rafiei M. The Relationship between Blood Biomarkers Level and the Prognosis of Nephrotic Syndrome in the Children. International Journal of Pediatrics. 2016; 4(9):3489-97.
2. Yousefichaijan P, Rezagholizamenjany M, Safi F, Rafiei F, Arjmand A. Detection of Extended-Spectrum Beta-Lactamases in Escherichia coli Isolates and it’s Correlation with Vesicoureteral Reflux Nephropathy. Arch Pediatr. 2018; 6(3):e12101.
3. Yousefichaijan P, Rezagholizamenjany M, Dorreh F, Rafiei M, Taherahmadi H, Niyakan Z, et al. Comparison of development indicators, according to ages and stages questionnaires in children with pollakiuria compared to healthy children. Nephro-Urology Monthly. 2017; 9(4).
4. Alinejad S, Yousefichaijan P, Rezagholizamenjany M, Rafie Y, Kahbazi M, Arjmand A. Nephrotoxic Effect of Gentamicin and Amikacin in Neonates with Infection. Nephro-Urology Monthly. 2018(In Press).
5. Salarzaei M, Saravani S, Heydari M, Aali H, Malekzadegan A, Soofi D, et al. Prevalence of Urinary Tract Infection in Children with Nephrotic Syndrome. International Journal of Pharmaceutical Sciences and Research. 2017; 8(7):1346-50.
6. Batishcheva G, Zhdanova O, Nastausheva T, Goncharova N, Chernov Y. New methods to detect early manifestations of adverse side effects of glucocorticosteroids in children. Research Results in Pharmacology. 2018; 4(1): 27–32.
7. Kari JA, Quinlan C, Deanfield J, Shroff R, Tullus K. Endothelial dysfunction in children with steroid-resistant nephrotic syndrome. Iranian Journal of Pediatrics. 2017; 27(4).
8. Tullus K, Webb H, Bagga A. Management of steroid-resistant nephrotic syndrome in children and adolescents. The Lancet Child & Adolescent Health. 2018.
9. Lieberman KV, Pavlova-Wolf A. Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance. Journal of nephrology. 2017; 30(1):35-44.
10. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, et al. Rituximab treatment for severe steroid-or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatric Nephrology. 2008; 23(8):1269.
11. Popko K, Górska E, Kuźma-Mroczkowska E. Effectiveness of rituximab in nephrotic syndrome treatment. Central-European journal of immunology. 2017; 42(3):313.
12. Ravani P, Rossi R, Bonanni A, Quinn RR, Sica F, Bodria M, et al. Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial. Journal of the American Society of Nephrology. 2015:ASN. 2014080799.
13. Aggarwal A, Yadav AK, Ramachandran R, Kumar V, Kumar V, Sachdeva N, et al. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome. Nephrology. 2016; 21(6):483-9.
14. Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, et al. Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediatric Nephrology. 2016; 31(3):465-72.
15. Banerjee S, Basu S, Sen A, Sengupta J. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome. Pediatric Nephrology. 2017; 32(11):2063-70.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |